110 related articles for article (PubMed ID: 3254058)
1. Blood leukocyte natural killer activity as an early diagnostic indicator of leukaemic relapse.
Tratkiewicz JA; Szer J; Boyd RL
Adv Exp Med Biol; 1988; 237():451-5. PubMed ID: 3254058
[No Abstract] [Full Text] [Related]
2. [The role of costimulatory molecules in immune responses in acute leukemia].
Cielińska S; Urbaniak-Kujda D; Kapelko-Słowik K; Kuliczkowski K
Pol Arch Med Wewn; 2001 May; 105(5):417-21. PubMed ID: 11865595
[No Abstract] [Full Text] [Related]
3. Cytotoxicity of purified Leu 19+ cells from the peripheral blood of children with acute lymphocytic leukemia.
Afify ZA; Abdel-Mageed A; Findley HW; Ragab AH
Cancer; 1990 Aug; 66(3):469-73. PubMed ID: 1694716
[TBL] [Abstract][Full Text] [Related]
4. Loss of natural killer activity as an indicator of relapse in acute leukaemia.
Tratkiewicz JA; Szer J
Clin Exp Immunol; 1990 May; 80(2):241-6. PubMed ID: 2357852
[TBL] [Abstract][Full Text] [Related]
5. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
6. [Natural killer activity--an index of the efficacy of the treatment of patients with acute leukemia].
Gashchuk AP; Evtukh VP; Kindzel'skiĭ AL
Lik Sprava; 1994; (5-6):79-81. PubMed ID: 7831919
[No Abstract] [Full Text] [Related]
7. Lymphokine-activated killer cytotoxicity against leukaemic blast cells.
Tratkiewicz JA; Szer J; Boyd RL
Clin Exp Immunol; 1990 Apr; 80(1):94-9. PubMed ID: 2323104
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of NK cell activity by IL-2.
Herberman RB
Prog Clin Biol Res; 1987; 244():267-74. PubMed ID: 3498952
[No Abstract] [Full Text] [Related]
9. Natural killer activity against viral targets in cyclosporine-treated renal allograft recipients.
Cauda R; Citterio F; Tamburrini E; Pozzetto U; Tumbarello M; Castagneto M; Ortona L
Transplant Proc; 1988 Apr; 20(2 Suppl 2):186-9. PubMed ID: 2834839
[No Abstract] [Full Text] [Related]
10. Some studies on natural killer cells in man.
Lotzová E; McCredie KB; Maroun JA; Dicke KA; Freireich EJ
Transplant Proc; 1979 Jun; 11(2):1390-2. PubMed ID: 314185
[No Abstract] [Full Text] [Related]
11. The effect of long-term cyclosporine therapy on natural killer cell activity.
Versluis DJ; Metselaar HJ; Bijma AM; Vaessen LM; Wenting GJ; Weimar W
Transplant Proc; 1988 Apr; 20(2 Suppl 2):179-85. PubMed ID: 3129839
[No Abstract] [Full Text] [Related]
12. An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation.
Gross C; Holler E; Stangl S; Dickinson A; Pockley AG; Asea AA; Mallappa N; Multhoff G
Leuk Res; 2008 Apr; 32(4):527-34. PubMed ID: 17543383
[TBL] [Abstract][Full Text] [Related]
13. First-line diagnosis based on immunological phenotyping in suspected acute leukemia: a prospective study.
Kristensen JS; Ellegaard J; Hansen KB; Clausen N; Hokland P
Leuk Res; 1988; 12(9):773-82. PubMed ID: 3193815
[TBL] [Abstract][Full Text] [Related]
14. The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.
Rettinger E; Kuçi S; Naumann I; Becker P; Kreyenberg H; Anzaghe M; Willasch A; Koehl U; Bug G; Ruthardt M; Klingebiel T; Fulda S; Bader P
Cytotherapy; 2012 Jan; 14(1):91-103. PubMed ID: 21973023
[TBL] [Abstract][Full Text] [Related]
15. Patterns of membrane CD45 isoform expression by leukaemic blasts and normal mature myeloid cells.
Master PS; Richards SJ; Roberts BE; Scott CS
Int J Hematol; 1992 Jun; 55(3):235-42. PubMed ID: 1386761
[TBL] [Abstract][Full Text] [Related]
16. [Effects of Cordyceps sinensis (CS) on in vitro natural killer cells].
Liu C; Lu S; Ji MR
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 May; 12(5):267-9, 259. PubMed ID: 1392475
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
Li X; Du W; Liu W; Li X; Li H; Huang SA
APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
[TBL] [Abstract][Full Text] [Related]
18. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
19. [Myeloid/natural killer cell precursor acute leukemia diagnosed by cell marker analysis].
Miura R; Yoshimi M; Kikuchi Y; Takahashi T
Rinsho Ketsueki; 2013 Jun; 54(6):579-83. PubMed ID: 23823098
[TBL] [Abstract][Full Text] [Related]
20. Detection of residual leukemia with immunologic methods: technical developments and clinical implications.
Campana D; Freitas RO; Coustan-Smith E
Leuk Lymphoma; 1994; 13 Suppl 1():31-4. PubMed ID: 8075576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
